276 results
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
EuroIntervention - Most discussed papers of the year
19 May 2021 – From EuroPCR 2021
Watch this session if you want to know the top 3 most discussed papers of the year which concern management of myocardial revascularisation failure, the impact of COVID-19 pandemic on interventional cardiology practice and Ischaemia witch non-obstructive coronary arteries.
This session was originally presented during EuroPCR 2021.
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
Is angio-based FFR ready to replace invasive FFR?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.
Meta-analysis of elective coronary revascularization vs medical therapy alone
18 May 2021 – From EuroPCR 2021
This session, originally broadcast during EuroPCR 2021, presents a meta-analysis based on 25 trials dealing with revascularization in patients with chronic coronary syndromes and enables our experts to discuss the strengths and weaknesses of this study.
Revascularisation for chronic coronary syndrome and multivessel disease (Part 1) - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation, to appraise how to select the optimal revascularisation strategy in such patients and to learn how to perform state-of-the-art PCI to achieve optimal procedural outcomes.
This session was originally presented...
Revascularisation for chronic coronary syndrome and multivessel disease - Part 2
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand when patients with CCS and MVD should undergo revascularisation and to appraise how to select the optimal revascularisation strategy in such patients.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 - Innovations in stents & scaffolds
18 May 2021 – From EuroPCR 2021
This session will enable you to find out more about arterial balloon with variable pressures, SPAS (stent positioning assistance systems), thrombectomy with a novel stent retriever in patients with large thrombus burden, and bionanosensored stents.
EuroPCR 2021 - Innovations in stable CAD
18 May 2021 – From EuroPCR 2021
In this session, consider the accuracy of OFR in assessing stenting result and residual disease, appraise a novel hybrid IVUS-OCT catheter system, and question whether NOCAD/INOCA patients could be diagnosed with a new physiological wire by obtaining pressure-derived CFR.
How to treat an occluded radial artery graft
18 May 2021 – From EuroPCR 2021
Watch this session and you will understand why it is essential to always consider revascularization of native vessels once patients are stented in either vein or arterial grafts.
